Comparison between Lusutrombopag and effectiveness of the platelet blood transfusion

Comparison between Lusutrombopag and effectiveness of the platelet blood transfusion - The usefulness of Lusutrombopag

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032777

Enrollment

Registered

2018-06-13

Start date

2018-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombopenia

Interventions

Lusutrombopag Platelet transfusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Thrombopenia having the chronic liver disease that scheduled elective bloody treatment Child-pugh A or B

Exclusion criteria

Exclusion criteria: Child-pugh C

Design outcomes

Primary

Measure	Time frame
Platelet growth rate	—

Countries

Japan

Contacts

Public ContactHirohito Takeuchi

Gastroenterology and Hepatology Tokyo Medical University

htake@tokyo-med.ac.jp0333426111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026